Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up (Q44023046)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up |
scientific article |
Statements
1 reference
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up (English)
1 reference
1 reference
David J Moliterno
1 reference
Marco Roffi
1 reference
Bernhard Meier
1 reference
Eric R Powers
1 reference
Cindy L Grines
1 reference
Peter M DiBattiste
1 reference
Howard C Herrmann
1 reference
Michel Bertrand
1 reference
Katherine E Harris
1 reference
Laura A Demopoulos
1 reference
TARGET Investigators
1 reference
1 June 2002
1 reference
1 reference
Identifiers
1 reference